Interactions between Immunosuppressive Therapy and Direct-Acting Antivirals in Kidney Transplant Recipient with Hepatitis C Infection
Hepatitis C virus (HCV) causes increased mortality and morbidity in kidney transplant patients. Interferon-based therapies are poorly tolerated and involve the risk of rejection. The new direct-acting antiviral drugs (DAAs) have revolutionized the treatment of HCV infection in transplant patients....
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2020-05-01
|
Series: | Journal of Renal and Hepatic Disorders |
Subjects: | |
Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/67 |